Table 1.
Recommended Line of Treatment
Level of Recommendation | Recommendation | Treatment |
---|---|---|
First-line | Physical examination and workup should be performed; trigger factors should be evaluated; if antidepressants are being taken, they should be stopped; emergency situations should be assessed and if an emergency is present, precautions should be taken. | Monotherapy - quetiapine, risperidone, valproate, lithium; if an emergency is present, olanzapine, haloperidol |
Second-line | Compliance to the treatment should be assessed; if there is no response to the first line of treatment despite adequate dose and period of medication, the second line should be implemented. | Monotherapy - olanzapine, haloperidol, carbamazepine; Along with MS - olanzapine, aripiprazole, haloperidol, quetiapine, risperidone, paliperidone |
Third-line | Factors that might complicate treatment should be assessed; personal and family history should be examined in detail. | Electroconvulsive therapy in addition to pharmacological treatment; for patients who present mixed features ziprasidone |
Fourth-line | Treatments with low levels of evidence can be utilized; drugs recommended at the earlier lines of treatment can be tried. | Chlorpromazine, pimozide, tamoxifen, allopurinol |
The recommendations in the table are based on the beneficial and adverse effect profiles of the drugs. MS: Mood Stabilizers